Medfirstindia Trading Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.17 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -63.33%
- Profit Growth -0.58%
- Ebitda 5.35%
- Net Worth -166.18%
- Total Assets -25.22%
About Medfirstindia Trading
Medfirstindia Trading Private Limited (MTPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 March 2015 (Nine years and ten months 29 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.17 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Agarwal, Neelam Agarwal, and Vivek Agarwal serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2015PTC098148
- Company No.
098148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Medfirstindia Trading Private Limited offer?
Medfirstindia Trading Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Blood Pressure Machine.
Who are the key members and board of directors at Medfirstindia Trading?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Agarwal  | Whole-Time Director | 25-Mar-2015 | Current |
| Neelam Agarwal | Director | 25-Mar-2015 | Current |
| Vivek Agarwal | Director | 25-Mar-2015 | Current |
Financial Performance of Medfirstindia Trading.
Medfirstindia Trading Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 63.33% decrease. The company also saw a slight decrease in profitability, with a 0.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 166.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medfirstindia Trading?
In 2017, Medfirstindia Trading had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medfirstindia Trading?
Unlock and access historical data on people associated with Medfirstindia Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medfirstindia Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medfirstindia Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
